ELI LILLY & Co Logo

ELI LILLY & Co

Pharma leader developing medicines for diabetes, obesity, oncology, and neuroscience.

LLY | US

Overview

Corporate Details

ISIN(s):
US5324571083
LEI:
Country:
United States of America
Address:
LILLY CORPORATE CTR, 46285 INDIANAPOLIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eli Lilly and Company is a global pharmaceutical corporation engaged in the discovery, development, manufacturing, and commercialization of human healthcare products. Founded in 1876, the company has a long history of medical innovation, focusing on creating medicines for significant health challenges. Its portfolio primarily targets non-communicable diseases, with key therapeutic areas including diabetes, oncology, immunology, and neuroscience. Lilly is widely recognized for its pioneering role in diabetes care and has more recently become a prominent leader in the development of novel therapies for obesity and related metabolic conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ELI LILLY & Co filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ELI LILLY & Co

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ELI LILLY & Co via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

A pharmaceutical specialist in drugs for renal, skin, and allergic diseases.
Japan
4551
Tourmaline Bio, Inc. Logo
Develops an anti-IL-6 antibody for cardiovascular, inflammatory, and immune diseases.
United States of America
TRML
TOWA PHARMACEUTICAL CO.,LTD. Logo
Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.
Japan
4553
Transcode Therapeutics, Inc. Logo
Develops targeted RNA therapies for metastatic cancer using a proprietary nanoparticle delivery platform.
United States of America
RNAZ
Travere Therapeutics, Inc. Logo
Develops therapies for rare kidney and metabolic diseases, with an FDA-approved treatment for IgA nephropathy.
United States of America
TVTX
Traws Pharma, Inc. Logo
Develops oral small-molecule therapies for respiratory viral diseases and cancer.
United States of America
TRAW
TScan Therapeutics, Inc. Logo
Developing TCR-engineered T-cell therapies for solid and hematologic cancers.
United States of America
TCRX
TSUMURA & CO. Logo
A leader in Japanese Kampo herbal medicine, producing prescription and OTC formulations.
Japan
4540
TuHURA Biosciences, Inc./NV Logo
Phase 3 immuno-oncology firm developing therapeutics to overcome cancer therapy resistance.
United States of America
HURA
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.
Türkiye
TRILC

Talk to a Data Expert

Have a question? We'll get back to you promptly.